Pharsight

Drugs that contain Epinephrine

1. Adrenaclick patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5665071 IMPAX Reloadable automatic or manual emergency injection system
May, 2013

(10 years ago)

US10166344 IMPAX Injection needle assembly
Jan, 2025

(8 months from now)

US10166334 IMPAX Medicine injection apparatuses
Jan, 2025

(8 months from now)

US7905352 IMPAX Kits containing medicine injection devices and containers
Apr, 2027

(2 years from now)

Market Authorisation Date: 25 November, 2009

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

ADRENACLICK family patents

Family Patents

2. Adrenalin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9119876 PAR STERILE PRODUCTS Epinephrine formulations
Mar, 2035

(10 years from now)

US9295657 PAR STERILE PRODUCTS Epinephrine formulations
Mar, 2035

(10 years from now)

US10130592 PAR STERILE PRODUCTS Epinephrine formulations
Mar, 2035

(10 years from now)

US11083698 PAR STERILE PRODUCTS Epinephrine compositions and containers
Mar, 2039

(14 years from now)

US10653646 PAR STERILE PRODUCTS Epinephrine compositions and containers
Mar, 2039

(14 years from now)

US11207280 PAR STERILE PRODUCTS Epinephrine compositions and containers
Mar, 2039

(14 years from now)

Market Authorisation Date: 07 December, 2012

Treatment: Emergency treatment of allergic reactions (type i), including anaphylaxis; To increase mean arterial blood pressure in adult patients with hypotension associated with septic shock

Dosage: SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS; SOLUTION;INTRAVENOUS

How can I launch a generic of ADRENALIN before it's drug patent expiration?
More Information on Dosage

ADRENALIN family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Auvi-q patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8361029 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US8313466 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US8425462 KALEO INC Devices, systems, and methods for medicament delivery
Nov, 2024

(6 months from now)

US8608698 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US10314977 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US9056170 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US9833573 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US8920377 KALEO INC Devices, systems and methods for medicament delivery
Nov, 2024

(6 months from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery
Jan, 2025

(7 months from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2025

(10 months from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery
Apr, 2025

(11 months from now)

US9149579 KALEO INC Devices, systems and methods for medicament delivery
Jul, 2025

(1 year, 1 month from now)

US9278182 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2026

(1 year, 8 months from now)

US9259539 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2026

(1 year, 8 months from now)

US8926594 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2026

(1 year, 10 months from now)

US7731686 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(2 years from now)

US10960155 KALEO INC Devices, systems and methods for medicament delivery
Jun, 2026

(2 years from now)

US11590286 KALEO INC Devices, systems and methods for medicament delivery
Dec, 2026

(2 years from now)

US9238108 KALEO INC Medicament delivery device having an electronic circuit system
Feb, 2027

(2 years from now)

US8206360 KALEO INC Devices, systems and methods for medicament delivery
Feb, 2027

(2 years from now)

US9724471 KALEO INC Devices, systems, and methods for medicament delivery
May, 2027

(3 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery
Mar, 2028

(3 years from now)

US7749194 KALEO INC Devices, systems, and methods for medicament delivery
Oct, 2028

(4 years from now)

US8231573 KALEO INC Medicament delivery device having an electronic circuit system
Nov, 2028

(4 years from now)

US8226610 KALEO INC Medical injector with compliance tracking and monitoring
Apr, 2029

(4 years from now)

US8021344 KALEO INC Medicament delivery device configured to produce an audible output
Nov, 2029

(5 years from now)

US10842938 KALEO INC Medicament delivery device and methods for delivering drugs to infants and children
Dec, 2037

(13 years from now)

US10688244 KALEO INC Medicament delivery device and methods for delivering drugs to infants and children
Dec, 2037

(13 years from now)

US11771830 KALEO INC Medicament delivery device and methods for delivering drugs to infants and children
Dec, 2037

(13 years from now)

Market Authorisation Date: 17 November, 2017

Treatment: Method to treat severe allergic emergencies in patients weighing 7.5 to 15 kg (16.5 to 33 lbs); Method of treating allergic reaction via injection; Method for confirming dose delivery; Method of treat...

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

AUVI-Q family patents

Family Patents

4. Epinephrine patents expiration

EPINEPHRINE IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10039728 BPI LABS More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(10 years from now)

US10004700 BPI LABS More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(10 years from now)

US9283197 BPI LABS More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(10 years from now)

Market Authorisation Date: 04 March, 2024

Treatment: Increasing mean arterial blood pressure in adult patients with hypotension associated with septic shock; Emergency treatment of allergic reactions (type 1), including anaphylaxis; A method of treating...

Dosage: SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS

How can I launch a generic of EPINEPHRINE before it's drug patent expiration?
More Information on Dosage

EPINEPHRINE family patents

Family Patents

5. Epipen patents expiration

EPIPEN's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7794432 MYLAN SPECIALITY LP Automatic injector with kickback attenuation
Sep, 2025

(1 year, 3 months from now)

US7449012 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(1 year, 3 months from now)

US8048035 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(1 year, 3 months from now)

US8870827 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(1 year, 3 months from now)

US9586010 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(1 year, 3 months from now)

Market Authorisation Date: 03 August, 1995

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

How can I launch a generic of EPIPEN before it's drug patent expiration?
More Information on Dosage

EPIPEN family patents

Family Patents

6. Epipen Jr. patents expiration

EPIPEN JR.'s oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8048035 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(1 year, 3 months from now)

US8870827 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(1 year, 3 months from now)

US9586010 MYLAN SPECIALITY LP Automatic injector with needle cover
Sep, 2025

(1 year, 3 months from now)

US7794432 MYLAN SPECIALITY LP Automatic injector with kickback attenuation
Sep, 2025

(1 year, 3 months from now)

US7449012 MYLAN SPECIALITY LP Automatic injector
Sep, 2025

(1 year, 3 months from now)

Market Authorisation Date: 03 August, 1995

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

How can I launch a generic of EPIPEN JR. before it's drug patent expiration?
More Information on Dosage

EPIPEN JR. family patents

Family Patents

7. Primatene Mist patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8367734 ARMSTRONG PHARMS Stable epinephrine suspension formulation with high inhalation delivery efficiency
Jan, 2026

(1 year, 8 months from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Nov 07, 2021

Market Authorisation Date: 07 November, 2018

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

PRIMATENE MIST family patents

Family Patents

8. Symjepi patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11141540 ADAMIS PHARMS CORP Syringe devices
Oct, 2036

(12 years from now)

Market Authorisation Date: 27 September, 2018

Treatment: A method for administering a therapeutic dose of epinephrine

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

SYMJEPI family patents

Family Patents

9. Twinject 0.15 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7297136 IMPAX Medicine injection devices and methods
Jan, 2025

(7 months from now)

US7621891 IMPAX Method and apparatus for delivering epinephrine
Feb, 2025

(8 months from now)

Market Authorisation Date: 25 November, 2009

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

TWINJECT 0.15 family patents

Family Patents

10. Twinject 0.3 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7297136 IMPAX Medicine injection devices and methods
Jan, 2025

(7 months from now)

US7621891 IMPAX Method and apparatus for delivering epinephrine
Feb, 2025

(8 months from now)

Market Authorisation Date: 25 November, 2009

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

TWINJECT 0.3 family patents

Family Patents